NCT02673736View on ClinicalTrials.gov

A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor

PHASE1TerminatedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions
Solid TumorsTenosynovial Giant Cell TumorSynovitis, Pigmented Villonodular
Interventions
DRUG

PLX73086

Trial Locations (3)

48201

Karmanos Cancer Institute, Detroit

78229

South Texas Accelerated Research Therapeutics, San Antonio

85258

HonorHealth, Scottsdale

Sponsors

Lead Sponsor

Plexxikon
All Listed Sponsors
lead

Plexxikon

INDUSTRY

NCT02673736 - A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor | Biotech Hunter | Biotech Hunter